Adult onset Still's disease after first cycle of pemetrexed and gemcitabine for non-small cell lung cancer

Lung Cancer

Volumn 64, Issue 1, 2009, Pages 124-126

  Bosch Barrera, Joaquim ^a   Montero, Alberto ^a   López Picazo, José María ^a   García Foncillas, Jesús ^a   Ferrer, Marta ^a   Yuste, José Ramón ^a   Gil Bazo, Ignacio ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Adult onset Still's disease; Arthralgia; Ferritin; Lung cancer; Pemetrexed; Skin rash

Indexed keywords

CARBOPLATIN; ERLOTINIB; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN; METHYLPREDNISOLONE; PACLITAXEL; PEMETREXED; VORICONAZOLE;

ADULT; ADULT ONSET STILL DISEASE; ADVANCED CANCER; ANTIBIOTIC THERAPY; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; ARTICLE; BRONCHOSCOPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANDIDA GLABRATA; CANDIDA LUSITANIAE; CANDIDIASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DEEP VEIN THROMBOSIS; DRUG WITHDRAWAL; DYSPNEA; FEBRILE NEUTROPENIA; FERRITIN BLOOD LEVEL; FEVER; HEART TAMPONADE; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PATCH TEST; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RASH; SIDE EFFECT; THORAX RADIOGRAPHY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; GLUTAMATES; GUANINE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; STILL'S DISEASE, ADULT-ONSET;

EID: 61449127247     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.09.013     Document Type: Article

References (20)

1. Mendelsohn L.G., Shih C., Chen V.J., Habeck L.L., Gates S.B., and Shackelford K.A. Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis. Semin Oncol 26 2 Suppl. 6 (1999) 42-47
2. Hanna N., Shepherd F.A., Fossella F.V., Pereira J.R., De Marinis F., von Pawel J., et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 22 9 (2004) 1589-1597
3. Monnerat C., and Le Chevalier T. Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer. Ann Oncol 17 Suppl. 5 (2006) v86-90
4. Scagliotti G.V., Kortsik C., Dark G.G., Price A., Manegold C., Rosell R., et al. Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial. Clin Cancer Res 11 2 Pt 1 (2005) 690-696
5. Zinner R.G., Fossella F.V., Gladish G.W., Glisson B.S., Blumenschein Jr. G.R., Papadimitrakopoulou V.A., et al. Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer. Cancer 104 11 (2005) 2449-2456
6. Scagliotti G.V., Parikh P., von Pawel J., Biesma B., Vansteenkiste J., Manegold C., et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26 21 (2008) 3543-3551
7. Treat J., Bonomi P., McCleod M., Christiansen N.P., Mintzer D.M., Monberg M.J., et al. Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial. Lung Cancer 53 1 (2006) 77-83
8. Ma C.X., Nair S., Thomas S., Mandrekar S.J., Nikcevich D.A., Rowland K.M., et al. Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer. J Clin Oncol 23 25 (2005) 5929-5937
9. Lopes G., Vincek V., and Raez L.E. Pemetrexed-associated urticarial vasculitis. Lung Cancer 51 2 (2006) 247-249
10. Tummino C., Barlesi F., Tchouhadjian C., Tasei A.M., Gaudy-Marqueste C., Richard M.A., et al. Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer. Rev Mal Respir 24 5 (2007) 635-638
11. Rusthoven J.J., Eisenhauer E., Butts C., Gregg R., Dancey J., Fisher B., et al. Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: a phase II study. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 17 4 (1999) 1194
12. Choi J.H., Suh C.H., Lee Y.M., Suh Y.J., Lee S.K., Kim S.S., et al. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 30 November (11) (2003) 2422-2427
13. Efthimiou P., Paik P.K., and Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 65 5 (2006) 564-572
14. Yamaguchi M., Ohta A., Tsunematsu T., Kasukawa R., Mizushima Y., Kashiwagi H., et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 19 3 (1992) 424-430
15. Cush J.J., Medsger Jr. T.A., Christy W.C., Herbert D.C., and Cooperstein L.A. Adult-onset Still's disease clinical course and outcome. Arthritis Rheum 30 2 (1987) 186-194
16. Calabro J.J., and Londino Jr. A.V. Adult onset Still's disease. J Rheumatol 13 4 (1986) 827-828
17. Iglesias J., Sathiraju S., and Marik P.E. Severe systemic inflammatory response syndrome with shock and ARDS resulting from Still's disease: clinical response with high-dose pulse methylprednisolone therapy. Chest 115 6 (1999) 1738-1740
18. Fautrel B., Le Moel G., Saint-Marcoux B., Taupin P., Vignes S., Rozenberg S., et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol 28 2 (2001) 322-329
19. Cush J.J. Adult-onset Still's disease. Bull Rheum Dis 49 6 (2000) 1-4
20. Uppal S.S., Al-Mutairi M., Hayat S., Abraham M., and Malaviya A. Ten years of clinical experience with adult onset Still's disease: is the outcome improving. Clin Rheumatol 26 7 (2007) 1055-1060